Glauco Souza,
Director of Global Business Development and Innovation, 3D Cell Culture at Greiner Bio-One; Adjunct Assistant Professor,
Greiner Bio-One and University of Texas Health Science Center at Houston
Dr. Glauco R. Souza is the Director of Global Business Development and Innovation, 3D Cell Culture at Greiner Bio-One and former President and co-founder of Nano3D Biosciences, Inc. (n3D). He is one of the creators of magnetic 3D cell culture, including magnetic 3D bioprinting. Dr. Souza is also Adjunct Assistant Professor at University of Texas Health Science Center at Houston. Prior to co-founding n3D, Dr. Souza was an Odyssey Scholar at UT MD Anderson Cancer Center. His work has been reported in various high-impact scientific journals, including Nature Nanotechnology, Proceedings of the National Academy of Sciences, Nature Protocols, Biomaterials, and Nature Reviews Cancer. Now, Glauco’s mission is to advance magnetic 3D cell culture into a routine laboratory tool that will measurably improve the drug discovery process, cancer research, personalized medicine, and regenerative medicine. Recently, his work was selected for the Short List of The 2017 Lush Prize for outstanding research producing an effective non-animal safety test. He was also an invited speaker at TEDx Houston. Dr. Souza’s research has been funded by grants from National Science Foundation (NSF), National Institute of Health (NIH), Department of Defense (DOD), Center for Advancement of Science in Space (CASIS), and Texas Emerging Technology Fund (ETF).
Magnetic 3D Bioprinting, from Spheroids to Fingerprinting Cells in 3D Using a 2D Workflow
Thursday, 13 June 2019 at 15:30
Add to Calendar ▼2019-06-13 15:30:002019-06-13 16:30:00Europe/LondonMagnetic 3D Bioprinting, from Spheroids to Fingerprinting Cells in 3D Using a 2D Workflow3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
The growing push for 3D cell culture models is limited by technical challenges in handling, processing, and scalability to high-throughput applications. To meet these challenges, we use our platform, magnetic 3D bioprinting, in which cells are individually magnetized and assembled with magnetic forces. In magnetizing cells, not only do we make routine cell culture and experiments feasible and scalable, but we also gain fine spatial control in the formation of spheroids and more complex structures. This presentation will focus on recent developments using this platform, particularly in cancer biology and immunology. Specifically, we will present a method for phenotypic profiling of cell types within spheroids using real-time high-throughput imaging. This label-free method allows for multiplexing with other assay endpoints for high-content screening. Overall, we use magnetic 3D bioprinting to create functionally and structurally representative spheroids for high-throughput screening.
Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2019-06-13 15:30:002019-06-13 16:30:00Europe/LondonMagnetic 3D Bioprinting, from Spheroids to Fingerprinting Cells in 3D Using a 2D Workflow3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
